Highlights
NASDAQ: ADAP       Adaptimmune Ther Ads
Last Price Today's Change   Day's Range   Trading Volume
9.79   -0.20 (2.00%)  9.39 - 10.19  696,300

Overview

 
Avg Volume (4 weeks):1,008,810
4 Weeks Range:8.85 - 11.90
4 Weeks Price Volatility (%):
30.82%
52 Weeks Range:0.709 - 13.40
52 Weeks Price Volatility (%):
71.55%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Adaptimmune Therapeutics PLC is UK based biopharmaceutical company focused on novel cancer immunotherapy products based on its proprietary Specific Peptide Enhanced Affinity Receptor T-cell platform. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. The company engineers TCRs to increase their affinity to cancer-specific peptides in order to destroy cancer cells in patients. Its programs include MAGE-A10 T-cell therapy, NON-SMALL CELL LUNG CANCER, AFP SPEAR T-cell, MAGE-A4 SPEAR T-cell therapy and NY-ESO SPEAR T-cell for multiple cancer types.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2452  5804  513  138 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 ZOM 0.168-0.057 
 GNUS 3.55+1.24 
 NIO 9.38+1.47 
 LK 1.38-1.62 
 SOLO 3.13+0.80 
 WKHS 20.91+1.73 
 AAL 12.50-0.31 
 JOB 1.50+0.986 
 SQQQ 7.14-0.15 
 GE 6.82+0.08 
Partners & Brokers